Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 3 Thoracic 2 Gastrointestinal 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 CNS 1 Breast 1

Conditions

All Solid Tumors 1

Interventions

Injections 98 pembrolizumab 90 Carboplatin 57 Paclitaxel 54 Cisplatin 52 Nivolumab 44 Docetaxel 43 Pemetrexed 42 Gemcitabine 37 atezolizumab 32 tislelizumab 29 Bevacizumab 29 toripalimab 23 Fluorouracil 23 Capecitabine 23 Irinotecan 22 Oxaliplatin 20 durvalumab 19 Ipilimumab 18 Leucovorin 17 Cetuximab 17 Rifampin 14 Itraconazole 14 olaparib 13 spartalizumab 12 Midazolam 12 Cyclophosphamide 12 trifluridine tipiracil drug combination 11 sintilimab 11 Drug Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Pharmaceutical Preparations × Other solid neoplasm × Clear all

NCT01711398 2015-02-12

IP N02

Elro Pharma

Phase 1/2 Completed

Other solid neoplasm

All Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡